Author:
DeWerd Larry A.,Huq M. Saiful,Das Indra J.,Ibbott Geoffrey S.,Hanson William F.,Slowey Thomas W.,Williamson Jeffrey F.,Coursey Bert M.
Reference14 articles.
1. Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes;Blasko;Semin Radiat. Oncol.,2002
2. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy;Grimm;Int. J. Radiat. Oncol., Biol., Phys.,2001
3. Palladium-103 brachytherapy for prostate carcinoma;Blasko;Int. J. Radiat. Oncol., Biol., Phys.,2000
4. I-125 versus Pd-103 for low-risk prostate cancer: Morbidity outcomes from a prospective randomized multicenter trial;Wallner;Cancer J. Sci. Am.,2002
5. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer;Zelefsky;Int. J. Radiat. Oncol., Biol., Phys.,2000
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献